Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
We initiate a study with research grant from department of health and Taoyuan mental hospital
and choose risperidone and olanzapine as study medications. We compare the incidence of using
anticholinergic drugs in schizophrenic patients of Han ethnics with neuroleptic-induced acute
dystonia or parkinsonism to test the hypothesis that these two medications have different EPS
incidence in EPS intolerant population.
Phase:
Phase 4
Details
Lead Sponsor:
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan